Characterization of gene expression in mucinous cystic neoplasms of the pancreas using oligonucleotide microarrays.
about
The life and works of S100P - from conception to cancerPancreatic adenocarcinoma pathology: changing "landscape"Insidious changes in stromal matrix fuel cancer progressionInsights into the Pathogenesis of Pancreatic Cystic Neoplasms.Pancreatic cancer.Rapid characterization of candidate biomarkers for pancreatic cancer using cell microarrays (CMAs).Molecular alterations in primary prostate cancer after androgen ablation therapy.Evidence of Notch pathway activation in the ectatic ducts of chronic pancreatitis.Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma.S100P: a novel therapeutic target for cancer.Pepsinogen C expression, regulation and its relationship with cancer.Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.The secret origins and surprising fates of pancreas tumorsSuppression of Aurora-A oncogenic potential by c-Myc downregulationCross-species antibody microarray interrogation identifies a 3-protein panel of plasma biomarkers for early diagnosis of pancreas cancer.Cystic precursors to invasive pancreatic cancer.Mixed epithelial and stromal tumour of the kidney with luteinised ovarian stromaA quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin.Xanthohumol-Mediated Suppression of Notch1 Signaling Is Associated with Antitumor Activity in Human Pancreatic Cancer Cells.Glycogen synthase kinase-3 inhibitor AR-A014418 suppresses pancreatic cancer cell growth via inhibition of GSK-3-mediated Notch1 expression.Exploring the tumour environment: cancer-associated fibroblasts as targets in cancer therapy.Identifying molecular markers for the early detection of pancreatic neoplasia.bHLH-Orange Transcription Factors in Development and Cancer.S100P/RAGE signaling regulates microRNA-155 expression via AP-1 activation in colon cancerTranscriptional regulation and functional implication of S100P in cancer.Progastriscin: structure, function, and its role in tumor progression.Novel quantitative analysis of the S100P protein combined with endoscopic ultrasound-guided fine needle aspiration cytology in the diagnosis of pancreatic adenocarcinoma.MYC in pancreatic cancer: novel mechanistic insights and their translation into therapeutic strategies.Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression.Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts.Cathepsin E deficiency induces a novel form of lysosomal storage disorder showing the accumulation of lysosomal membrane sialoglycoproteins and the elevation of lysosomal pH in macrophages.[Precursor lesions of pancreatobiliary cancer].Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells
P2860
Q26749135-CBFB93DC-E5E3-4596-96F0-4804FD0469A5Q26799446-C2B707FE-207C-41F7-B6C5-443C7B6EBF7FQ26851261-DFACD684-1950-4F61-B284-0D9EFB4801E0Q30234478-764EFBB0-047F-4C40-B133-83D6ADEA9436Q30490247-29A3DFCB-5103-4F85-9DAB-15AF03D67854Q30534663-82677025-B192-4BB3-8299-DE0148B2278EQ33224548-19D53897-24E8-445B-9094-D5151376F3B7Q33309441-1D65DE27-CA66-4AD4-954A-31E479F84F1EQ33336057-B31380DC-C497-4EE0-85BB-D85B30D903B5Q33699305-E2E1EDAD-EF82-4982-877A-52EF125AC518Q33722750-E5792959-0A42-4671-8171-47CFA9D502BAQ33738887-610BB532-56C9-4F96-B347-101A2C55F1B1Q33827679-F033E7F5-8664-45E0-A3C3-3A42CDE40805Q34355817-1E35482F-E9A2-42C8-B2A2-3FC057615B84Q35343764-69790F2F-3CD1-40A1-BE7C-81A863A8FE63Q35609914-0B9FE188-A0AB-445C-BC90-2FA66E91CD8AQ35770565-03CD7AD9-1EC5-40F8-8FAB-D50C0AA1EBDDQ35790227-6D633836-5930-4C26-9314-C462721EDBC6Q36010627-F062396F-3335-4B49-AD5C-70ABD87AC4DCQ36019650-3EA6CCCD-FE19-4F4B-9496-EBACDEB20E9DQ36318551-29878924-3499-4030-B540-18C14E8FDD7AQ36328508-A2AE42F6-6AEB-4C94-86E0-CC355EB03B86Q36790868-52F4EED3-C60C-4B45-A628-729F244583FFQ37053083-EC29BFA4-11CE-49C1-BED7-957C5534B952Q37692260-77FD56D0-5A09-4571-BB63-D4ACC242ACEEQ37709723-84FBCC88-CACA-4068-B1CC-6C39220602F8Q37722098-39D6D02F-12DE-4C65-B00A-8133CFA9723DQ38539670-C5B4A076-AEFB-4DC4-8EC6-F3D129240692Q39017730-67A2404A-16F4-4C77-A7C5-E6D59ECCD636Q46867228-0EF174A3-6ECF-42F0-B36B-4628013C820AQ52574876-4A3CF5C9-9665-4C54-AC40-5274773AAE32Q53220247-222B6C3E-4912-40DB-89F6-79DAEE82DCA1Q56749698-662B6033-02A6-456A-98EC-0877E0BE70A1
P2860
Characterization of gene expression in mucinous cystic neoplasms of the pancreas using oligonucleotide microarrays.
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Characterization of gene expre ...... g oligonucleotide microarrays.
@ast
Characterization of gene expre ...... g oligonucleotide microarrays.
@en
type
label
Characterization of gene expre ...... g oligonucleotide microarrays.
@ast
Characterization of gene expre ...... g oligonucleotide microarrays.
@en
prefLabel
Characterization of gene expre ...... g oligonucleotide microarrays.
@ast
Characterization of gene expre ...... g oligonucleotide microarrays.
@en
P2093
P2860
P356
P1433
P1476
Characterization of gene expre ...... g oligonucleotide microarrays.
@en
P2093
Nijaguna Prasad
Norihiro Sato
Noriyoshi Fukushima
Steven D Leach
P2860
P2888
P304
P356
10.1038/SJ.ONC.1208117
P407
P577
2004-12-01T00:00:00Z
P5875
P6179
1031989293